XIST and neoplasm: Furthermore, the loss of Xist results in the secretion of exosomal microRNA-503, promoting the transition of microglia, a key component of the brain's innate immune system, from a tumor-suppressive (M1 pro-inflammatory) phenotype to a tumor-promoting (M2 anti-inflammatory) phenotype [74].